CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.

CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary. — المؤلف: Xue, Yibo — Nature communications 20190410

المؤلف
Xue, Yibo
النشر
Nature communications 20190410
الوصف
558 p.
الموضوعات
Aminopyridines؛ Animals؛ Benzimidazoles؛ Carcinoma, Small Cell؛ Cell Line, Tumor؛ Cell Survival؛ Chromatin Immunoprecipitation؛ Cyclin D1